CAPR logo

Capricor Therapeutics (CAPR) CAPEX

Annual CAPEX

$2.05 M
-$1.31 M-39.06%

December 31, 2023

Summary

Performance

1-Year Change

-39.06%

3-Year Change

+273.9%

5-Year Change

+546.92%

15-Year Change

+6258.7%

CAPR CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

44.83%
CAPR annual capital expenditures is higher than 44.83% of companies in Healthcare sector

High & Low

All-time High

$3.36 M
CAPR annual capital expenditures is currently -39.06% below its historical high of $3.36 million

3-Year Low

$1.20 M
CAPR annual capital expenditures is currently +71.15% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CAPR previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
CAPR next annual earnings announcement is scheduled for Feb 28, 2025

OtherCAPRcash flowmetrics:

Annual FCF

-$27.64 M
CAPR annual free cash flow is -$27.64 million

Annual CFO

-$25.60 M
CAPR annual cash flow from operations is -$25.60 million

Annual CFI

$5.11 M
CAPR annual cash flow from investing activities is $5.11 million

Annual CFF

$25.58 M
CAPR annual cash flow from financing activities is $25.58 million

Quarterly CAPEX

$59.00 K
-$21.90 K-27.07%

September 30, 2024

Summary

Performance

3-Month Change

-27.07%

1-Year Change

-27.07%

3-Year Change

-95.17%

5-Year Change

-95.17%

CAPR Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

25%
CAPR quarterly capital expenditures is higher than 25% of companies in Healthcare sector

High & Low

All-time High

$1.22 M
CAPR quarterly capital expenditures is currently -95.17% below its historical high of $1.22 million

3-Year Low

$59.00 K
CAPR quarterly capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CAPR previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
CAPR next earnings announcement is scheduled for Feb 28, 2025

OtherCAPRcash flowmetrics:

Quarterly FCF

-$11.70 M
CAPR quarterly free cash flow is -$11.70 million

Quarterly CFO

-$11.64 M
CAPR quarterly cash flow from operations is -$11.64 million

Quarterly CFI

$2.00 M
CAPR quarterly cash flow from investing activities is $2.00 million

Quarterly CFF

$67.33 M
CAPR quarterly cash flow from financing activities is $67.33 million

TTM CAPEX

$1.53 M
-$572.80 K-27.20%

September 30, 2024

Summary

Performance

3-Month Change

-27.2%

1-Year Change

-27.2%

3-Year Change

-54.36%

5-Year Change

-54.36%

CAPR TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

40%
CAPR TTM capital expenditures is higher than 40% of companies in Healthcare sector

High & Low

All-time High

$3.36 M
CAPR TTM capital expenditures is currently -54.36% below its historical high of $3.36 million

3-Year Low

$1.20 M
CAPR TTM capital expenditures is currently +28.18% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CAPR previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
CAPR next earnings announcement is scheduled for Feb 28, 2025

OtherCAPRcash flowmetrics:

TTM FCF

-$38.33 M
CAPR TTM free cash flow is -$38.33 million

TTM CFO

-$36.79 M
CAPR TTM cash flow from operations is -$36.79 million

TTM CFI

$1.33 M
CAPR TTM cash flow from investing activities is $1.33 million

TTM CFF

$94.85 M
CAPR TTM cash flow from financing activities is $94.85 million

CAPR CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-39.1%-27.1%-27.2%
3 y3 years+273.9%-95.2%-54.4%
5 y5 years+546.9%-95.2%-54.4%

CAPR CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-39.1%+71.2%-95.2%at low-54.4%+28.2%
5 y5-year-39.1%+273.9%-95.2%+59.9%-54.4%+1326.4%
alltimeall time-39.1%>+9999.0%-95.2%+278.8%-54.4%>+9999.0%

Capricor Therapeutics CAPEX History

DateAnnualQuarterlyTTM
Sep 2024
-
$59.00 K(-27.1%)
$1.53 M(-27.2%)
Jun 2024
-
$80.90 K(-87.8%)
$2.11 M(-6.8%)
Mar 2024
-
$664.30 K(-8.9%)
$2.26 M(+10.3%)
Dec 2023
$2.05 M(-39.1%)
$729.20 K(+15.4%)
$2.05 M(-19.4%)
Sep 2023
-
$631.80 K(+170.7%)
$2.54 M(-15.5%)
Jun 2023
-
$233.40 K(-48.5%)
$3.01 M(-5.6%)
Mar 2023
-
$453.10 K(-62.9%)
$3.19 M(-5.1%)
Dec 2022
$3.36 M(+180.8%)
$1.22 M(+11.2%)
$3.36 M(+34.1%)
Sep 2022
-
$1.10 M(+166.4%)
$2.51 M(+33.7%)
Jun 2022
-
$412.60 K(-34.0%)
$1.87 M(+5.0%)
Mar 2022
-
$625.40 K(+69.6%)
$1.78 M(+49.2%)
Dec 2021
$1.20 M(+118.5%)
$368.70 K(-21.3%)
$1.20 M(+7.2%)
Sep 2021
-
$468.20 K(+45.2%)
$1.12 M(+39.5%)
Jun 2021
-
$322.50 K(+774.0%)
$799.50 K(+36.8%)
Mar 2021
-
$36.90 K(-87.2%)
$584.50 K(+6.7%)
Dec 2020
$547.60 K(+73.0%)
$288.10 K(+89.5%)
$547.60 K(+111.0%)
Sep 2020
-
$152.00 K(+41.4%)
$259.50 K(+141.4%)
Jun 2020
-
$107.50 K(-789.1%)
$107.50 K(-66.0%)
Dec 2018
$316.50 K(+882.9%)
-$15.60 K(-110.7%)
$316.50 K(-4.7%)
Sep 2018
-
$145.50 K(>+9900.0%)
$332.10 K(+63.7%)
Jun 2018
-
$200.00(-99.9%)
$202.90 K(-5.8%)
Mar 2018
-
$186.40 K(>+9900.0%)
$215.40 K(+571.0%)
Dec 2017
$32.20 K(-83.4%)
$0.00(-100.0%)
$32.10 K(-76.7%)
Sep 2017
-
$16.30 K(+28.3%)
$137.60 K(+4.2%)
Jun 2017
-
$12.70 K(+309.7%)
$132.10 K(-12.5%)
Mar 2017
-
$3100.00(-97.1%)
$151.00 K(-22.0%)
Dec 2016
$193.70 K
$105.50 K(+876.9%)
$193.70 K(+107.2%)
Sep 2016
-
$10.80 K(-65.8%)
$93.50 K(-44.5%)
Jun 2016
-
$31.60 K(-31.0%)
$168.40 K(+5.2%)
DateAnnualQuarterlyTTM
Mar 2016
-
$45.80 K(+764.2%)
$160.10 K(+5.9%)
Dec 2015
$151.20 K(-18.9%)
$5300.00(-93.8%)
$151.20 K(-6.6%)
Sep 2015
-
$85.70 K(+267.8%)
$161.90 K(+52.2%)
Jun 2015
-
$23.30 K(-36.9%)
$106.40 K(-18.4%)
Mar 2015
-
$36.90 K(+130.6%)
$130.40 K(-30.0%)
Dec 2014
$186.40 K(+232.3%)
$16.00 K(-47.0%)
$186.40 K(+35.7%)
Sep 2014
-
$30.20 K(-36.2%)
$137.40 K(+0.6%)
Jun 2014
-
$47.30 K(-49.1%)
$136.60 K(+1.3%)
Mar 2014
-
$92.90 K(-381.5%)
$134.90 K(+140.5%)
Dec 2013
$56.10 K(-45.5%)
-$33.00 K(-212.2%)
$56.10 K(-37.0%)
Sep 2013
-
$29.40 K(-35.5%)
$89.10 K(+49.2%)
Jun 2013
-
$45.60 K(+223.4%)
$59.70 K(+323.4%)
Mar 2013
-
$14.10 K(-4800.0%)
$14.10 K(-61.6%)
Dec 2012
$103.00 K(+5050.0%)
-
-
Dec 2011
$2000.00(-9.1%)
-
-
Dec 2010
$2200.00(-94.0%)
-
-
Dec 2009
$36.70 K(-60.4%)
-$300.00(-101.1%)
$36.70 K(-29.4%)
Sep 2009
-
$26.20 K(+223.5%)
$52.00 K(+53.8%)
Jun 2009
-
$8100.00(+200.0%)
$33.80 K(-46.3%)
Mar 2009
-
$2700.00(-82.0%)
$62.90 K(-32.1%)
Dec 2008
$92.60 K(-67.9%)
$15.00 K(+87.5%)
$92.70 K(-58.7%)
Sep 2008
-
$8000.00(-78.5%)
$224.30 K(-26.4%)
Jun 2008
-
$37.20 K(+14.5%)
$304.80 K(+1.9%)
Mar 2008
-
$32.50 K(-77.8%)
$299.20 K(+3.6%)
Dec 2007
$288.90 K(+435.0%)
$146.60 K(+65.6%)
$288.90 K(+103.0%)
Sep 2007
-
$88.50 K(+180.1%)
$142.30 K(+164.5%)
Jun 2007
-
$31.60 K(+42.3%)
$53.80 K(+142.3%)
Mar 2007
-
$22.20 K
$22.20 K
Dec 2006
$54.00 K
-
-

FAQ

  • What is Capricor Therapeutics annual capital expenditures?
  • What is the all time high annual CAPEX for Capricor Therapeutics?
  • What is Capricor Therapeutics annual CAPEX year-on-year change?
  • What is Capricor Therapeutics quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Capricor Therapeutics?
  • What is Capricor Therapeutics quarterly CAPEX year-on-year change?
  • What is Capricor Therapeutics TTM capital expenditures?
  • What is the all time high TTM CAPEX for Capricor Therapeutics?
  • What is Capricor Therapeutics TTM CAPEX year-on-year change?

What is Capricor Therapeutics annual capital expenditures?

The current annual CAPEX of CAPR is $2.05 M

What is the all time high annual CAPEX for Capricor Therapeutics?

Capricor Therapeutics all-time high annual capital expenditures is $3.36 M

What is Capricor Therapeutics annual CAPEX year-on-year change?

Over the past year, CAPR annual capital expenditures has changed by -$1.31 M (-39.06%)

What is Capricor Therapeutics quarterly capital expenditures?

The current quarterly CAPEX of CAPR is $59.00 K

What is the all time high quarterly CAPEX for Capricor Therapeutics?

Capricor Therapeutics all-time high quarterly capital expenditures is $1.22 M

What is Capricor Therapeutics quarterly CAPEX year-on-year change?

Over the past year, CAPR quarterly capital expenditures has changed by -$21.90 K (-27.07%)

What is Capricor Therapeutics TTM capital expenditures?

The current TTM CAPEX of CAPR is $1.53 M

What is the all time high TTM CAPEX for Capricor Therapeutics?

Capricor Therapeutics all-time high TTM capital expenditures is $3.36 M

What is Capricor Therapeutics TTM CAPEX year-on-year change?

Over the past year, CAPR TTM capital expenditures has changed by -$572.80 K (-27.20%)